Skip to main content
SpringerLink
Log in

Amino-Terminal Pro-B-Type Natriuretic Peptide in Refractory Kawasaki Disease

  • Case Report
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Serum concentrations of brain natriuretic peptide and its amino-terminal cleavage pro-fragment, NT-proBNP, have never been reported in refractory Kawasaki disease. Changes in NT-proBNP levels after infliximab treatment in an infant with severe cardiovascular complications are reported here. The regular evaluation of this cardiac biomarker after infliximab treatment may have clinical relevance in patients with refractory Kawasaki disease and severe heart involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Burns JC, Mason WH, Haugher SB et al (2005) Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 146:662–667

    Article  PubMed  CAS  Google Scholar 

  2. Burns JC, Best BM, Mejas A et al (2008) Infliximab treatment of immunoglobulin-resistant Kawasaki disease. J Pediatr 153:833–838

    Article  PubMed  CAS  Google Scholar 

  3. de Benedictis FM, Lattanzi B, Colaneri M (2008) Home monitoring anticoagulation therapy in infants. Arch Dis Child 93:714

    PubMed  Google Scholar 

  4. Johns MC, Stephenson C (2008) Amino-terminal pro-B-type natriuretic peptide testing in neonatal and pediatric patients. Am J Cardiol 10(Suppl):76A–81A

    Article  CAS  Google Scholar 

  5. Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42:241–248

    Article  PubMed  CAS  Google Scholar 

  6. Kurotobi S, Kawakami N, Shimizu K et al (2005) Brain natriuretic peptide as hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 26:425–430

    Article  PubMed  CAS  Google Scholar 

  7. Ma KK, Ogawa T, deBold AJ (2004) Selective upregulation of cardiac brain natriuretic peptide as the transcriptional and translational levels by proinflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36:505–513

    Article  PubMed  CAS  Google Scholar 

  8. Matsubara T, Furukawa S, Yabuta K (1990) Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 56:29–36

    Article  PubMed  CAS  Google Scholar 

  9. McCrindle BW, Li JS, Minich LL et al (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179

    Article  PubMed  Google Scholar 

  10. O’Connor MJ, Saulsbury FT (2007) Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab. Clin Pediatr (Phila) 46:345–348

    Article  Google Scholar 

  11. Oishi T, Fujieda M, Shiraishi T et al (2008) Infliximab treatment for refractory Kawasaki disease with coronary artery aneurysm. Circ J 72:850–852

    Article  PubMed  CAS  Google Scholar 

  12. Williams RV, Wilke VM, Tani LY, Minch LL (2002) Does abciximab enhance regression of coronary aneurysm resulting from Kawasaki disease? Pediatrics 109(1):E4

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Salesi Children’s Hospital, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy

    Fernando Maria de Benedictis & Patrizia Osimani

  2. Department of Cardiovascular Medicine, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy

    Massimo Colaneri & Maria Grazia Bettuzzi

Authors
  1. Fernando Maria de Benedictis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Massimo Colaneri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrizia Osimani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Grazia Bettuzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fernando Maria de Benedictis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Benedictis, F.M., Colaneri, M., Osimani, P. et al. Amino-Terminal Pro-B-Type Natriuretic Peptide in Refractory Kawasaki Disease. Pediatr Cardiol 30, 837–839 (2009). https://doi.org/10.1007/s00246-009-9416-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-009-9416-3

Keywords

Search

Navigation